Inventor
LELETI MANMOHAN REDDY
US64 patents
⚠️ This page may combine multiple inventors who share the name “LELETI MANMOHAN REDDY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHEMOCENTRYX INC
29 patentsUS10035768B2Jul 31, 2018
C5aR antagonists
CHEMOCENTRYX INC23 citations94
US9834545B2Dec 5, 2017
Modulators of chemokine receptors
CHEMOCENTRYX INC26 citations94
US9809581B2Nov 7, 2017
Inhibitors of CXCR2
CHEMOCENTRYX INC23 citations94
US9573897B2Feb 21, 2017
C5AR antagonists
CHEMOCENTRYX INC24 citations94
US8906938B2Dec 9, 2014
C5aR antagonists
CHEMOCENTRYX INC28 citations92
US7807704B2Oct 5, 2010
Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2
CHEMOCENTRYX INC30 citations92
US11142521B2Oct 12, 2021
Substituted anilines as CCR(4) antagonists
CHEMOCENTRYX INC4 citations84
US10660897B2May 26, 2020
C5aR antagonists
CHEMOCENTRYX INC6 citations84
US10370363B2Aug 6, 2019
Inhibitors of CXCR2
CHEMOCENTRYX INC6 citations84
US10336736B2Jul 2, 2019
Modulators of chemokine receptors
CHEMOCENTRYX INC6 citations84
US9758512B2Sep 12, 2017
Substituted anilines as CCR(4) antagonists
CHEMOCENTRYX INC6 citations84
US9567323B2Feb 14, 2017
Substituted anilines as CCR(4) antagonists
CHEMOCENTRYX INC6 citations84
US8835419B2Sep 16, 2014
Substituted anilines as CCR(4) antagonists
CHEMOCENTRYX INC9 citations83
US9340509B2May 17, 2016
CCR6 compounds
CHEMOCENTRYX INC4 citations82
US11434230B2Sep 6, 2022
2-oxindole compounds
CHEMOCENTRYX INC1 citations73
US11040960B2Jun 22, 2021
Inhibitors of CXCR2
CHEMOCENTRYX INC3 citations73
US10988464B2Apr 27, 2021
Modulators of chemokine receptors
CHEMOCENTRYX INC3 citations73
US10759789B2Sep 1, 2020
2-oxindole compounds
CHEMOCENTRYX INC2 citations73
US10421748B2Sep 24, 2019
2-oxindole compounds
CHEMOCENTRYX INC3 citations73
US10407417B2Sep 10, 2019
Substituted anilines as CCR(4) antagonists
CHEMOCENTRYX INC3 citations73
US9790204B2Oct 17, 2017
Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
CHEMOCENTRYX INC2 citations73
US9795599B2Oct 24, 2017
CCR6 compounds
CHEMOCENTRYX INC2 citations72
US9150550B2Oct 6, 2015
Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
CHEMOCENTRYX INC2 citations63
US8685959B2Apr 1, 2014
Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
CHEMOCENTRYX INC2 citations63
US12139475B2Nov 12, 2024
2-oxindole compounds
CHEMOCENTRYX INC0 citations62
US11945805B2Apr 2, 2024
Inhibitors of CXCR2
CHEMOCENTRYX INC0 citations62
US11884654B2Jan 30, 2024
Substituted anilines as CCR(4) antagonists
CHEMOCENTRYX INC0 citations62
US11820759B2Nov 21, 2023
Modulators of chemokine receptors
CHEMOCENTRYX INC0 citations62
US10117865B2Nov 6, 2018
CCR6 compounds
CHEMOCENTRYX INC1 citations62
ARCUS BIOSCIENCES INC
18 patentsUS11001603B2May 11, 2021
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC13 citations93
US10239912B2Mar 26, 2019
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC23 citations93
US10981944B2Apr 20, 2021
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC11 citations84
US11667662B2Jun 6, 2023
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC4 citations83
US10399962B2Sep 3, 2019
Azolopyrimidine for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC13 citations80
US11633416B1Apr 25, 2023
Oral formulations of CD73 compounds
ARCUS BIOSCIENCES INC4 citations73
US11058704B2Jul 13, 2021
Inhibitors of adenosine 5′-nucleotidase
ARCUS BIOSCIENCES INC4 citations71
US12145901B1Nov 19, 2024
Process for preparing tetralin compounds
ARCUS BIOSCIENCES INC2 citations69
US11787762B2Oct 17, 2023
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
ARCUS BIOSCIENCES INC2 citations69
US11407712B2Aug 9, 2022
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
ARCUS BIOSCIENCES INC3 citations69
US11072597B2Jul 27, 2021
Azolopyrimidine for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC3 citations69
US12168023B2Dec 17, 2024
Inhibitors of adenosine 5′-nucleotidase
ARCUS BIOSCIENCES INC1 citations61
US11993584B2May 28, 2024
Solid forms of an azolopyrimidine compound
ARCUS BIOSCIENCES INC0 citations61
US11267845B2Mar 8, 2022
Inhibitors of CD73-mediated immunosuppression
ARCUS BIOSCIENCES INC1 citations61
US11045472B2Jun 29, 2021
Quinazoline-pyridine derivatives for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC1 citations61
US12459967B2Nov 4, 2025
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC0 citations60
US12195447B2Jan 14, 2025
Azolopyrimidine for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC1 citations60
US12103907B2Oct 1, 2024
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
ARCUS BIOSCIENCES INC0 citations59
FAN PINGCHEN
2 patentsCHARVAT TREVOR T
1 patentShowing the top 50 of 64 patents by PatentIndex Score.